nodes	percent_of_prediction	percent_of_DWPC	metapath
Diphenhydramine—Cloperastine—Raloxifene—osteoporosis	0.281	1	CrCrCtD
Diphenhydramine—SLC22A1—Estropipate—osteoporosis	0.12	0.21	CbGbCtD
Diphenhydramine—SLC22A2—Estradiol—osteoporosis	0.0572	0.1	CbGbCtD
Diphenhydramine—SLC22A1—Estradiol—osteoporosis	0.0497	0.0873	CbGbCtD
Diphenhydramine—CYP2B6—Raloxifene—osteoporosis	0.0477	0.0838	CbGbCtD
Diphenhydramine—CYP2B6—Ethinyl Estradiol—osteoporosis	0.0461	0.0809	CbGbCtD
Diphenhydramine—CYP1A2—Estropipate—osteoporosis	0.0419	0.0736	CbGbCtD
Diphenhydramine—CYP2C9—Estropipate—osteoporosis	0.0378	0.0664	CbGbCtD
Diphenhydramine—CYP2B6—Cholecalciferol—osteoporosis	0.0368	0.0647	CbGbCtD
Diphenhydramine—CYP2C19—Cholecalciferol—osteoporosis	0.0234	0.0411	CbGbCtD
Diphenhydramine—CYP1A2—Conjugated Estrogens—osteoporosis	0.0198	0.0348	CbGbCtD
Diphenhydramine—CYP2C9—Cholecalciferol—osteoporosis	0.0195	0.0342	CbGbCtD
Diphenhydramine—CYP2C19—Estradiol—osteoporosis	0.0189	0.0331	CbGbCtD
Diphenhydramine—CYP2D6—Cholecalciferol—osteoporosis	0.0178	0.0313	CbGbCtD
Diphenhydramine—CYP1A2—Estradiol—osteoporosis	0.0174	0.0306	CbGbCtD
Diphenhydramine—CYP2C9—Estradiol—osteoporosis	0.0157	0.0276	CbGbCtD
Diphenhydramine—Nasal congestion—Estradiol—osteoporosis	0.000674	0.00509	CcSEcCtD
Diphenhydramine—Sweating increased—Zoledronate—osteoporosis	0.000671	0.00507	CcSEcCtD
Diphenhydramine—Confusional state—Etidronic acid—osteoporosis	0.000665	0.00503	CcSEcCtD
Diphenhydramine—Dizziness—Calcium Acetate—osteoporosis	0.000664	0.00502	CcSEcCtD
Diphenhydramine—Sweating increased—Conjugated Estrogens—osteoporosis	0.000646	0.00488	CcSEcCtD
Diphenhydramine—Vomiting—Calcium Acetate—osteoporosis	0.000639	0.00483	CcSEcCtD
Diphenhydramine—Asthenia—Ergocalciferol—osteoporosis	0.000637	0.00481	CcSEcCtD
Diphenhydramine—Pollakiuria—Zoledronate—osteoporosis	0.000636	0.00481	CcSEcCtD
Diphenhydramine—Vertigo—Estropipate—osteoporosis	0.000628	0.00475	CcSEcCtD
Diphenhydramine—Agranulocytosis—Pamidronate—osteoporosis	0.000627	0.00474	CcSEcCtD
Diphenhydramine—Dysuria—Conjugated Estrogens—osteoporosis	0.00062	0.00468	CcSEcCtD
Diphenhydramine—Vertigo—Alendronate—osteoporosis	0.000619	0.00467	CcSEcCtD
Diphenhydramine—Palpitations—Estropipate—osteoporosis	0.000618	0.00467	CcSEcCtD
Diphenhydramine—Vertigo—Raloxifene—osteoporosis	0.000608	0.0046	CcSEcCtD
Diphenhydramine—Agitation—Calcitriol—osteoporosis	0.000603	0.00456	CcSEcCtD
Diphenhydramine—Vertigo—Ibandronate—osteoporosis	0.000602	0.00455	CcSEcCtD
Diphenhydramine—Nausea—Calcium Acetate—osteoporosis	0.000597	0.00451	CcSEcCtD
Diphenhydramine—Palpitations—Ibandronate—osteoporosis	0.000592	0.00448	CcSEcCtD
Diphenhydramine—Paraesthesia—Etidronic acid—osteoporosis	0.000592	0.00448	CcSEcCtD
Diphenhydramine—Tinnitus—Risedronate—osteoporosis	0.000592	0.00447	CcSEcCtD
Diphenhydramine—Irritability—Estradiol—osteoporosis	0.000586	0.00443	CcSEcCtD
Diphenhydramine—Dyspepsia—Etidronic acid—osteoporosis	0.00058	0.00439	CcSEcCtD
Diphenhydramine—Neuropathy peripheral—Conjugated Estrogens—osteoporosis	0.000579	0.00438	CcSEcCtD
Diphenhydramine—Agranulocytosis—Zoledronate—osteoporosis	0.000573	0.00433	CcSEcCtD
Diphenhydramine—Convulsion—Calcitriol—osteoporosis	0.000569	0.0043	CcSEcCtD
Diphenhydramine—Constipation—Etidronic acid—osteoporosis	0.000564	0.00426	CcSEcCtD
Diphenhydramine—Dry mouth—Ibandronate—osteoporosis	0.000558	0.00422	CcSEcCtD
Diphenhydramine—Dry mouth—Calcitriol—osteoporosis	0.000546	0.00413	CcSEcCtD
Diphenhydramine—Feeling abnormal—Etidronic acid—osteoporosis	0.000543	0.00411	CcSEcCtD
Diphenhydramine—Chills—Pamidronate—osteoporosis	0.000541	0.00409	CcSEcCtD
Diphenhydramine—Thrombocytopenia—Raloxifene—osteoporosis	0.000541	0.00409	CcSEcCtD
Diphenhydramine—Hyperhidrosis—Raloxifene—osteoporosis	0.000534	0.00404	CcSEcCtD
Diphenhydramine—Hyperhidrosis—Ibandronate—osteoporosis	0.000529	0.004	CcSEcCtD
Diphenhydramine—Nausea—Ergocalciferol—osteoporosis	0.000527	0.00398	CcSEcCtD
Diphenhydramine—Urticaria—Etidronic acid—osteoporosis	0.000524	0.00396	CcSEcCtD
Diphenhydramine—Sweating increased—Estradiol—osteoporosis	0.000517	0.00391	CcSEcCtD
Diphenhydramine—Insomnia—Estropipate—osteoporosis	0.000516	0.0039	CcSEcCtD
Diphenhydramine—Tension—Pamidronate—osteoporosis	0.000515	0.00389	CcSEcCtD
Diphenhydramine—Paraesthesia—Estropipate—osteoporosis	0.000512	0.00387	CcSEcCtD
Diphenhydramine—Anorexia—Calcitriol—osteoporosis	0.00051	0.00386	CcSEcCtD
Diphenhydramine—Nervousness—Pamidronate—osteoporosis	0.00051	0.00385	CcSEcCtD
Diphenhydramine—Somnolence—Estropipate—osteoporosis	0.000507	0.00383	CcSEcCtD
Diphenhydramine—Dyspepsia—Estropipate—osteoporosis	0.000502	0.0038	CcSEcCtD
Diphenhydramine—Insomnia—Raloxifene—osteoporosis	0.0005	0.00378	CcSEcCtD
Diphenhydramine—Vertigo—Risedronate—osteoporosis	0.000496	0.00375	CcSEcCtD
Diphenhydramine—Insomnia—Ibandronate—osteoporosis	0.000495	0.00374	CcSEcCtD
Diphenhydramine—Dyspepsia—Alendronate—osteoporosis	0.000495	0.00374	CcSEcCtD
Diphenhydramine—Chills—Zoledronate—osteoporosis	0.000494	0.00374	CcSEcCtD
Diphenhydramine—Fatigue—Estropipate—osteoporosis	0.000492	0.00372	CcSEcCtD
Diphenhydramine—Paraesthesia—Ibandronate—osteoporosis	0.000491	0.00371	CcSEcCtD
Diphenhydramine—Pollakiuria—Estradiol—osteoporosis	0.00049	0.0037	CcSEcCtD
Diphenhydramine—Constipation—Estropipate—osteoporosis	0.000488	0.00369	CcSEcCtD
Diphenhydramine—Dyspepsia—Raloxifene—osteoporosis	0.000486	0.00368	CcSEcCtD
Diphenhydramine—Insomnia—Calcitriol—osteoporosis	0.000484	0.00366	CcSEcCtD
Diphenhydramine—Photosensitivity reaction—Estradiol—osteoporosis	0.000484	0.00366	CcSEcCtD
Diphenhydramine—Agitation—Pamidronate—osteoporosis	0.000483	0.00365	CcSEcCtD
Diphenhydramine—Dyspepsia—Ibandronate—osteoporosis	0.000482	0.00364	CcSEcCtD
Diphenhydramine—Constipation—Alendronate—osteoporosis	0.000481	0.00363	CcSEcCtD
Diphenhydramine—Somnolence—Calcitriol—osteoporosis	0.000476	0.0036	CcSEcCtD
Diphenhydramine—Decreased appetite—Ibandronate—osteoporosis	0.000476	0.00359	CcSEcCtD
Diphenhydramine—Fatigue—Ibandronate—osteoporosis	0.000472	0.00356	CcSEcCtD
Diphenhydramine—Constipation—Ibandronate—osteoporosis	0.000468	0.00354	CcSEcCtD
Diphenhydramine—Decreased appetite—Calcitriol—osteoporosis	0.000466	0.00352	CcSEcCtD
Diphenhydramine—Neuropathy peripheral—Estradiol—osteoporosis	0.000464	0.0035	CcSEcCtD
Diphenhydramine—Feeling abnormal—Alendronate—osteoporosis	0.000463	0.0035	CcSEcCtD
Diphenhydramine—Dry mouth—Risedronate—osteoporosis	0.00046	0.00348	CcSEcCtD
Diphenhydramine—Constipation—Calcitriol—osteoporosis	0.000458	0.00346	CcSEcCtD
Diphenhydramine—Convulsion—Pamidronate—osteoporosis	0.000455	0.00344	CcSEcCtD
Diphenhydramine—Tension—Conjugated Estrogens—osteoporosis	0.000453	0.00343	CcSEcCtD
Diphenhydramine—Urticaria—Estropipate—osteoporosis	0.000453	0.00343	CcSEcCtD
Diphenhydramine—Vision blurred—Zoledronate—osteoporosis	0.000452	0.00342	CcSEcCtD
Diphenhydramine—Diarrhoea—Etidronic acid—osteoporosis	0.000451	0.00341	CcSEcCtD
Diphenhydramine—Feeling abnormal—Ibandronate—osteoporosis	0.000451	0.00341	CcSEcCtD
Diphenhydramine—Tremor—Zoledronate—osteoporosis	0.000449	0.0034	CcSEcCtD
Diphenhydramine—Nervousness—Conjugated Estrogens—osteoporosis	0.000449	0.00339	CcSEcCtD
Diphenhydramine—Urticaria—Alendronate—osteoporosis	0.000446	0.00337	CcSEcCtD
Diphenhydramine—Toremifene—ESR1—osteoporosis	0.000444	0.156	CrCbGaD
Diphenhydramine—Agitation—Zoledronate—osteoporosis	0.000441	0.00333	CcSEcCtD
Diphenhydramine—Vision blurred—Conjugated Estrogens—osteoporosis	0.000435	0.00329	CcSEcCtD
Diphenhydramine—Urticaria—Ibandronate—osteoporosis	0.000435	0.00328	CcSEcCtD
Diphenhydramine—Bifonazole—CYP19A1—osteoporosis	0.000434	0.152	CrCbGaD
Diphenhydramine—Confusional state—Pamidronate—osteoporosis	0.000432	0.00327	CcSEcCtD
Diphenhydramine—Vertigo—Zoledronate—osteoporosis	0.000431	0.00326	CcSEcCtD
Diphenhydramine—Urticaria—Calcitriol—osteoporosis	0.000425	0.00322	CcSEcCtD
Diphenhydramine—Palpitations—Zoledronate—osteoporosis	0.000424	0.0032	CcSEcCtD
Diphenhydramine—Thrombocytopenia—Pamidronate—osteoporosis	0.00042	0.00317	CcSEcCtD
Diphenhydramine—Vomiting—Etidronic acid—osteoporosis	0.000419	0.00317	CcSEcCtD
Diphenhydramine—Tachycardia—Pamidronate—osteoporosis	0.000418	0.00316	CcSEcCtD
Diphenhydramine—Clomifene—CYP19A1—osteoporosis	0.000417	0.146	CrCbGaD
Diphenhydramine—Rash—Etidronic acid—osteoporosis	0.000416	0.00314	CcSEcCtD
Diphenhydramine—Convulsion—Zoledronate—osteoporosis	0.000416	0.00314	CcSEcCtD
Diphenhydramine—Dermatitis—Etidronic acid—osteoporosis	0.000415	0.00314	CcSEcCtD
Diphenhydramine—Vertigo—Conjugated Estrogens—osteoporosis	0.000415	0.00314	CcSEcCtD
Diphenhydramine—Hyperhidrosis—Pamidronate—osteoporosis	0.000414	0.00313	CcSEcCtD
Diphenhydramine—Headache—Etidronic acid—osteoporosis	0.000413	0.00312	CcSEcCtD
Diphenhydramine—Asthenia—Estropipate—osteoporosis	0.000409	0.00309	CcSEcCtD
Diphenhydramine—Anorexia—Pamidronate—osteoporosis	0.000409	0.00309	CcSEcCtD
Diphenhydramine—Palpitations—Conjugated Estrogens—osteoporosis	0.000408	0.00308	CcSEcCtD
Diphenhydramine—Insomnia—Risedronate—osteoporosis	0.000408	0.00308	CcSEcCtD
Diphenhydramine—Paraesthesia—Risedronate—osteoporosis	0.000405	0.00306	CcSEcCtD
Diphenhydramine—Asthenia—Alendronate—osteoporosis	0.000403	0.00305	CcSEcCtD
Diphenhydramine—Hypotension—Pamidronate—osteoporosis	0.0004	0.00303	CcSEcCtD
Diphenhydramine—Convulsion—Conjugated Estrogens—osteoporosis	0.0004	0.00302	CcSEcCtD
Diphenhydramine—Dry mouth—Zoledronate—osteoporosis	0.000399	0.00302	CcSEcCtD
Diphenhydramine—Fatigue—Ethinyl Estradiol—osteoporosis	0.000399	0.00301	CcSEcCtD
Diphenhydramine—Dyspepsia—Risedronate—osteoporosis	0.000397	0.003	CcSEcCtD
Diphenhydramine—Tinnitus—Estradiol—osteoporosis	0.000396	0.00299	CcSEcCtD
Diphenhydramine—Constipation—Ethinyl Estradiol—osteoporosis	0.000395	0.00299	CcSEcCtD
Diphenhydramine—Confusional state—Zoledronate—osteoporosis	0.000395	0.00298	CcSEcCtD
Diphenhydramine—Asthenia—Ibandronate—osteoporosis	0.000393	0.00297	CcSEcCtD
Diphenhydramine—Nausea—Etidronic acid—osteoporosis	0.000392	0.00296	CcSEcCtD
Diphenhydramine—Diarrhoea—Estropipate—osteoporosis	0.00039	0.00295	CcSEcCtD
Diphenhydramine—Fatigue—Risedronate—osteoporosis	0.000389	0.00294	CcSEcCtD
Diphenhydramine—Insomnia—Pamidronate—osteoporosis	0.000388	0.00293	CcSEcCtD
Diphenhydramine—Constipation—Risedronate—osteoporosis	0.000386	0.00291	CcSEcCtD
Diphenhydramine—Paraesthesia—Pamidronate—osteoporosis	0.000385	0.00291	CcSEcCtD
Diphenhydramine—Diarrhoea—Alendronate—osteoporosis	0.000384	0.00291	CcSEcCtD
Diphenhydramine—Asthenia—Calcitriol—osteoporosis	0.000384	0.0029	CcSEcCtD
Diphenhydramine—Clomifene—ESR1—osteoporosis	0.000384	0.134	CrCbGaD
Diphenhydramine—Thrombocytopenia—Zoledronate—osteoporosis	0.000383	0.0029	CcSEcCtD
Diphenhydramine—Tachycardia—Zoledronate—osteoporosis	0.000382	0.00289	CcSEcCtD
Diphenhydramine—Feeling abnormal—Ethinyl Estradiol—osteoporosis	0.000381	0.00288	CcSEcCtD
Diphenhydramine—Chills—Estradiol—osteoporosis	0.000381	0.00288	CcSEcCtD
Diphenhydramine—Somnolence—Pamidronate—osteoporosis	0.000381	0.00288	CcSEcCtD
Diphenhydramine—Hyperhidrosis—Zoledronate—osteoporosis	0.000378	0.00286	CcSEcCtD
Diphenhydramine—Diarrhoea—Raloxifene—osteoporosis	0.000378	0.00286	CcSEcCtD
Diphenhydramine—Dyspepsia—Pamidronate—osteoporosis	0.000377	0.00285	CcSEcCtD
Diphenhydramine—Dizziness—Estropipate—osteoporosis	0.000377	0.00285	CcSEcCtD
Diphenhydramine—Diarrhoea—Ibandronate—osteoporosis	0.000374	0.00283	CcSEcCtD
Diphenhydramine—Anorexia—Zoledronate—osteoporosis	0.000373	0.00282	CcSEcCtD
Diphenhydramine—Decreased appetite—Pamidronate—osteoporosis	0.000373	0.00282	CcSEcCtD
Diphenhydramine—Dizziness—Alendronate—osteoporosis	0.000372	0.00281	CcSEcCtD
Diphenhydramine—Fatigue—Pamidronate—osteoporosis	0.00037	0.00279	CcSEcCtD
Diphenhydramine—Tachycardia—Conjugated Estrogens—osteoporosis	0.000368	0.00278	CcSEcCtD
Diphenhydramine—Urticaria—Ethinyl Estradiol—osteoporosis	0.000367	0.00278	CcSEcCtD
Diphenhydramine—Constipation—Pamidronate—osteoporosis	0.000367	0.00277	CcSEcCtD
Diphenhydramine—Diarrhoea—Calcitriol—osteoporosis	0.000366	0.00277	CcSEcCtD
Diphenhydramine—Hypotension—Zoledronate—osteoporosis	0.000366	0.00276	CcSEcCtD
Diphenhydramine—Dizziness—Raloxifene—osteoporosis	0.000365	0.00276	CcSEcCtD
Diphenhydramine—Hyperhidrosis—Conjugated Estrogens—osteoporosis	0.000364	0.00275	CcSEcCtD
Diphenhydramine—Tension—Estradiol—osteoporosis	0.000363	0.00274	CcSEcCtD
Diphenhydramine—Vomiting—Estropipate—osteoporosis	0.000363	0.00274	CcSEcCtD
Diphenhydramine—Dizziness—Ibandronate—osteoporosis	0.000362	0.00273	CcSEcCtD
Diphenhydramine—Rash—Estropipate—osteoporosis	0.00036	0.00272	CcSEcCtD
Diphenhydramine—Dermatitis—Estropipate—osteoporosis	0.000359	0.00272	CcSEcCtD
Diphenhydramine—Anorexia—Conjugated Estrogens—osteoporosis	0.000359	0.00272	CcSEcCtD
Diphenhydramine—Nervousness—Estradiol—osteoporosis	0.000359	0.00271	CcSEcCtD
Diphenhydramine—Urticaria—Risedronate—osteoporosis	0.000358	0.00271	CcSEcCtD
Diphenhydramine—Headache—Estropipate—osteoporosis	0.000357	0.0027	CcSEcCtD
Diphenhydramine—Vomiting—Alendronate—osteoporosis	0.000357	0.0027	CcSEcCtD
Diphenhydramine—Rash—Alendronate—osteoporosis	0.000354	0.00268	CcSEcCtD
Diphenhydramine—Insomnia—Zoledronate—osteoporosis	0.000354	0.00268	CcSEcCtD
Diphenhydramine—Dermatitis—Alendronate—osteoporosis	0.000354	0.00268	CcSEcCtD
Diphenhydramine—Feeling abnormal—Pamidronate—osteoporosis	0.000353	0.00267	CcSEcCtD
Diphenhydramine—Hypotension—Conjugated Estrogens—osteoporosis	0.000352	0.00266	CcSEcCtD
Diphenhydramine—Headache—Alendronate—osteoporosis	0.000352	0.00266	CcSEcCtD
Diphenhydramine—Paraesthesia—Zoledronate—osteoporosis	0.000352	0.00266	CcSEcCtD
Diphenhydramine—Vomiting—Raloxifene—osteoporosis	0.000351	0.00266	CcSEcCtD
Diphenhydramine—Rash—Raloxifene—osteoporosis	0.000348	0.00263	CcSEcCtD
Diphenhydramine—Dermatitis—Raloxifene—osteoporosis	0.000348	0.00263	CcSEcCtD
Diphenhydramine—Somnolence—Zoledronate—osteoporosis	0.000348	0.00263	CcSEcCtD
Diphenhydramine—Vomiting—Ibandronate—osteoporosis	0.000348	0.00263	CcSEcCtD
Diphenhydramine—Tremor—Estradiol—osteoporosis	0.000346	0.00262	CcSEcCtD
Diphenhydramine—Headache—Raloxifene—osteoporosis	0.000346	0.00262	CcSEcCtD
Diphenhydramine—Rash—Ibandronate—osteoporosis	0.000345	0.00261	CcSEcCtD
Diphenhydramine—Dermatitis—Ibandronate—osteoporosis	0.000345	0.0026	CcSEcCtD
Diphenhydramine—Dyspepsia—Zoledronate—osteoporosis	0.000345	0.0026	CcSEcCtD
Diphenhydramine—Headache—Ibandronate—osteoporosis	0.000343	0.00259	CcSEcCtD
Diphenhydramine—Insomnia—Conjugated Estrogens—osteoporosis	0.000341	0.00258	CcSEcCtD
Diphenhydramine—Vomiting—Calcitriol—osteoporosis	0.000341	0.00257	CcSEcCtD
Diphenhydramine—Decreased appetite—Zoledronate—osteoporosis	0.00034	0.00257	CcSEcCtD
Diphenhydramine—Agitation—Estradiol—osteoporosis	0.00034	0.00257	CcSEcCtD
Diphenhydramine—Nausea—Estropipate—osteoporosis	0.000339	0.00256	CcSEcCtD
Diphenhydramine—Paraesthesia—Conjugated Estrogens—osteoporosis	0.000338	0.00256	CcSEcCtD
Diphenhydramine—Rash—Calcitriol—osteoporosis	0.000338	0.00255	CcSEcCtD
Diphenhydramine—Fatigue—Zoledronate—osteoporosis	0.000338	0.00255	CcSEcCtD
Diphenhydramine—Dermatitis—Calcitriol—osteoporosis	0.000337	0.00255	CcSEcCtD
Diphenhydramine—Headache—Calcitriol—osteoporosis	0.000336	0.00254	CcSEcCtD
Diphenhydramine—Somnolence—Conjugated Estrogens—osteoporosis	0.000335	0.00253	CcSEcCtD
Diphenhydramine—Constipation—Zoledronate—osteoporosis	0.000335	0.00253	CcSEcCtD
Diphenhydramine—Nausea—Alendronate—osteoporosis	0.000334	0.00252	CcSEcCtD
Diphenhydramine—Vertigo—Estradiol—osteoporosis	0.000332	0.00251	CcSEcCtD
Diphenhydramine—Dyspepsia—Conjugated Estrogens—osteoporosis	0.000332	0.00251	CcSEcCtD
Diphenhydramine—Asthenia—Ethinyl Estradiol—osteoporosis	0.000332	0.00251	CcSEcCtD
Diphenhydramine—Nausea—Raloxifene—osteoporosis	0.000328	0.00248	CcSEcCtD
Diphenhydramine—Decreased appetite—Conjugated Estrogens—osteoporosis	0.000328	0.00248	CcSEcCtD
Diphenhydramine—Palpitations—Estradiol—osteoporosis	0.000327	0.00247	CcSEcCtD
Diphenhydramine—Levomethadyl Acetate—CYP19A1—osteoporosis	0.000326	0.114	CrCbGaD
Diphenhydramine—Fatigue—Conjugated Estrogens—osteoporosis	0.000325	0.00246	CcSEcCtD
Diphenhydramine—Nausea—Ibandronate—osteoporosis	0.000325	0.00246	CcSEcCtD
Diphenhydramine—Asthenia—Risedronate—osteoporosis	0.000323	0.00244	CcSEcCtD
Diphenhydramine—Feeling abnormal—Zoledronate—osteoporosis	0.000323	0.00244	CcSEcCtD
Diphenhydramine—Constipation—Conjugated Estrogens—osteoporosis	0.000322	0.00244	CcSEcCtD
Diphenhydramine—Nausea—Calcitriol—osteoporosis	0.000318	0.0024	CcSEcCtD
Diphenhydramine—Diarrhoea—Ethinyl Estradiol—osteoporosis	0.000316	0.00239	CcSEcCtD
Diphenhydramine—Urticaria—Zoledronate—osteoporosis	0.000311	0.00235	CcSEcCtD
Diphenhydramine—Diarrhoea—Risedronate—osteoporosis	0.000308	0.00233	CcSEcCtD
Diphenhydramine—Dry mouth—Estradiol—osteoporosis	0.000308	0.00233	CcSEcCtD
Diphenhydramine—Asthenia—Pamidronate—osteoporosis	0.000308	0.00232	CcSEcCtD
Diphenhydramine—Dizziness—Ethinyl Estradiol—osteoporosis	0.000306	0.00231	CcSEcCtD
Diphenhydramine—Confusional state—Estradiol—osteoporosis	0.000304	0.0023	CcSEcCtD
Diphenhydramine—Urticaria—Conjugated Estrogens—osteoporosis	0.000299	0.00226	CcSEcCtD
Diphenhydramine—Dizziness—Risedronate—osteoporosis	0.000298	0.00225	CcSEcCtD
Diphenhydramine—Tachycardia—Estradiol—osteoporosis	0.000294	0.00223	CcSEcCtD
Diphenhydramine—Vomiting—Ethinyl Estradiol—osteoporosis	0.000294	0.00222	CcSEcCtD
Diphenhydramine—Diarrhoea—Pamidronate—osteoporosis	0.000293	0.00222	CcSEcCtD
Diphenhydramine—Hyperhidrosis—Estradiol—osteoporosis	0.000292	0.0022	CcSEcCtD
Diphenhydramine—Rash—Ethinyl Estradiol—osteoporosis	0.000292	0.0022	CcSEcCtD
Diphenhydramine—Dermatitis—Ethinyl Estradiol—osteoporosis	0.000291	0.0022	CcSEcCtD
Diphenhydramine—Headache—Ethinyl Estradiol—osteoporosis	0.00029	0.00219	CcSEcCtD
Diphenhydramine—Tamoxifen—ESR2—osteoporosis	0.000288	0.101	CrCbGaD
Diphenhydramine—Vomiting—Risedronate—osteoporosis	0.000287	0.00217	CcSEcCtD
Diphenhydramine—Rash—Risedronate—osteoporosis	0.000284	0.00215	CcSEcCtD
Diphenhydramine—Dermatitis—Risedronate—osteoporosis	0.000284	0.00215	CcSEcCtD
Diphenhydramine—Dizziness—Pamidronate—osteoporosis	0.000283	0.00214	CcSEcCtD
Diphenhydramine—Headache—Risedronate—osteoporosis	0.000282	0.00213	CcSEcCtD
Diphenhydramine—Asthenia—Zoledronate—osteoporosis	0.000281	0.00212	CcSEcCtD
Diphenhydramine—Nausea—Ethinyl Estradiol—osteoporosis	0.000275	0.00208	CcSEcCtD
Diphenhydramine—Insomnia—Estradiol—osteoporosis	0.000273	0.00206	CcSEcCtD
Diphenhydramine—Vomiting—Pamidronate—osteoporosis	0.000273	0.00206	CcSEcCtD
Diphenhydramine—Paraesthesia—Estradiol—osteoporosis	0.000271	0.00205	CcSEcCtD
Diphenhydramine—Asthenia—Conjugated Estrogens—osteoporosis	0.00027	0.00204	CcSEcCtD
Diphenhydramine—Rash—Pamidronate—osteoporosis	0.00027	0.00204	CcSEcCtD
Diphenhydramine—Dermatitis—Pamidronate—osteoporosis	0.00027	0.00204	CcSEcCtD
Diphenhydramine—Headache—Pamidronate—osteoporosis	0.000269	0.00203	CcSEcCtD
Diphenhydramine—Somnolence—Estradiol—osteoporosis	0.000268	0.00203	CcSEcCtD
Diphenhydramine—Diarrhoea—Zoledronate—osteoporosis	0.000268	0.00202	CcSEcCtD
Diphenhydramine—Nausea—Risedronate—osteoporosis	0.000268	0.00202	CcSEcCtD
Diphenhydramine—Dyspepsia—Estradiol—osteoporosis	0.000266	0.00201	CcSEcCtD
Diphenhydramine—Decreased appetite—Estradiol—osteoporosis	0.000262	0.00198	CcSEcCtD
Diphenhydramine—Fatigue—Estradiol—osteoporosis	0.00026	0.00197	CcSEcCtD
Diphenhydramine—Dizziness—Zoledronate—osteoporosis	0.000259	0.00196	CcSEcCtD
Diphenhydramine—Constipation—Estradiol—osteoporosis	0.000258	0.00195	CcSEcCtD
Diphenhydramine—Diarrhoea—Conjugated Estrogens—osteoporosis	0.000258	0.00195	CcSEcCtD
Diphenhydramine—Nausea—Pamidronate—osteoporosis	0.000255	0.00192	CcSEcCtD
Diphenhydramine—Dizziness—Conjugated Estrogens—osteoporosis	0.000249	0.00188	CcSEcCtD
Diphenhydramine—Vomiting—Zoledronate—osteoporosis	0.000249	0.00188	CcSEcCtD
Diphenhydramine—Feeling abnormal—Estradiol—osteoporosis	0.000249	0.00188	CcSEcCtD
Diphenhydramine—Rash—Zoledronate—osteoporosis	0.000247	0.00187	CcSEcCtD
Diphenhydramine—Dermatitis—Zoledronate—osteoporosis	0.000247	0.00186	CcSEcCtD
Diphenhydramine—Headache—Zoledronate—osteoporosis	0.000245	0.00185	CcSEcCtD
Diphenhydramine—Vomiting—Conjugated Estrogens—osteoporosis	0.00024	0.00181	CcSEcCtD
Diphenhydramine—Urticaria—Estradiol—osteoporosis	0.00024	0.00181	CcSEcCtD
Diphenhydramine—Rash—Conjugated Estrogens—osteoporosis	0.000238	0.0018	CcSEcCtD
Diphenhydramine—Dermatitis—Conjugated Estrogens—osteoporosis	0.000237	0.00179	CcSEcCtD
Diphenhydramine—Headache—Conjugated Estrogens—osteoporosis	0.000236	0.00178	CcSEcCtD
Diphenhydramine—Nausea—Zoledronate—osteoporosis	0.000233	0.00176	CcSEcCtD
Diphenhydramine—Nausea—Conjugated Estrogens—osteoporosis	0.000224	0.00169	CcSEcCtD
Diphenhydramine—Asthenia—Estradiol—osteoporosis	0.000216	0.00164	CcSEcCtD
Diphenhydramine—Diarrhoea—Estradiol—osteoporosis	0.000206	0.00156	CcSEcCtD
Diphenhydramine—Dizziness—Estradiol—osteoporosis	0.0002	0.00151	CcSEcCtD
Diphenhydramine—Tamoxifen—CYP19A1—osteoporosis	0.000193	0.0675	CrCbGaD
Diphenhydramine—Vomiting—Estradiol—osteoporosis	0.000192	0.00145	CcSEcCtD
Diphenhydramine—Methadone—CYP19A1—osteoporosis	0.000191	0.067	CrCbGaD
Diphenhydramine—Rash—Estradiol—osteoporosis	0.00019	0.00144	CcSEcCtD
Diphenhydramine—Dermatitis—Estradiol—osteoporosis	0.00019	0.00144	CcSEcCtD
Diphenhydramine—Headache—Estradiol—osteoporosis	0.000189	0.00143	CcSEcCtD
Diphenhydramine—Nausea—Estradiol—osteoporosis	0.000179	0.00135	CcSEcCtD
Diphenhydramine—Tamoxifen—ESR1—osteoporosis	0.000177	0.0621	CrCbGaD
Diphenhydramine—CHRM2—SIDS Susceptibility Pathways—TNF—osteoporosis	1.4e-05	0.000945	CbGpPWpGaD
Diphenhydramine—SLC22A2—Transmembrane transport of small molecules—ADCY5—osteoporosis	1.4e-05	0.000945	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling by GPCR—WNT1—osteoporosis	1.39e-05	0.000943	CbGpPWpGaD
Diphenhydramine—CHRM2—GPCR downstream signaling—PTHLH—osteoporosis	1.39e-05	0.000939	CbGpPWpGaD
Diphenhydramine—SLC22A1—Metabolism—ACP5—osteoporosis	1.38e-05	0.000935	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—MGLL—osteoporosis	1.38e-05	0.000935	CbGpPWpGaD
Diphenhydramine—SLC22A2—Metabolism—TPI1—osteoporosis	1.38e-05	0.000933	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—PKM—osteoporosis	1.36e-05	0.000924	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—FDPS—osteoporosis	1.36e-05	0.000924	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—MGLL—osteoporosis	1.36e-05	0.00092	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—PKM—osteoporosis	1.35e-05	0.000916	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—FDPS—osteoporosis	1.35e-05	0.000916	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—LRP5—osteoporosis	1.35e-05	0.000912	CbGpPWpGaD
Diphenhydramine—PTGS1—Metabolism—TPI1—osteoporosis	1.34e-05	0.000906	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—LRP5—osteoporosis	1.33e-05	0.000898	CbGpPWpGaD
Diphenhydramine—SLC22A1—Transmembrane transport of small molecules—ADCY5—osteoporosis	1.3e-05	0.000881	CbGpPWpGaD
Diphenhydramine—SLC22A2—Metabolism—P4HB—osteoporosis	1.29e-05	0.000877	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—PGLS—osteoporosis	1.29e-05	0.000876	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—GPD2—osteoporosis	1.29e-05	0.000876	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—LRP6—osteoporosis	1.29e-05	0.000873	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—ATIC—osteoporosis	1.29e-05	0.000871	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—PNP—osteoporosis	1.29e-05	0.000871	CbGpPWpGaD
Diphenhydramine—SLC22A1—Metabolism—TPI1—osteoporosis	1.28e-05	0.000869	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—GPD2—osteoporosis	1.28e-05	0.000869	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—PGLS—osteoporosis	1.28e-05	0.000869	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling by GPCR—PTHLH—osteoporosis	1.28e-05	0.000867	CbGpPWpGaD
Diphenhydramine—SLC22A2—Metabolism—GAPDH—osteoporosis	1.27e-05	0.000861	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism of lipids and lipoproteins—P4HB—osteoporosis	1.27e-05	0.000859	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—LRP6—osteoporosis	1.27e-05	0.000859	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling by GPCR—PTHLH—osteoporosis	1.26e-05	0.000853	CbGpPWpGaD
Diphenhydramine—PTGS1—Metabolism—P4HB—osteoporosis	1.26e-05	0.000851	CbGpPWpGaD
Diphenhydramine—HRH1—GPCR downstream signaling—CALCA—osteoporosis	1.24e-05	0.000841	CbGpPWpGaD
Diphenhydramine—SLC22A2—Metabolism—RAP1A—osteoporosis	1.24e-05	0.000838	CbGpPWpGaD
Diphenhydramine—PTGS1—Metabolism—GAPDH—osteoporosis	1.23e-05	0.000836	CbGpPWpGaD
Diphenhydramine—CYP1A2—Biological oxidations—POMC—osteoporosis	1.23e-05	0.00083	CbGpPWpGaD
Diphenhydramine—CHRM2—GPCR downstream signaling—CALCA—osteoporosis	1.22e-05	0.000827	CbGpPWpGaD
Diphenhydramine—SLC22A1—Metabolism—P4HB—osteoporosis	1.21e-05	0.000817	CbGpPWpGaD
Diphenhydramine—CYP2C18—Metabolism—CYP19A1—osteoporosis	1.2e-05	0.000816	CbGpPWpGaD
Diphenhydramine—PTGS1—Metabolism—RAP1A—osteoporosis	1.2e-05	0.000814	CbGpPWpGaD
Diphenhydramine—CYP2B6—Metabolism—IDH2—osteoporosis	1.2e-05	0.000813	CbGpPWpGaD
Diphenhydramine—SLC22A1—Metabolism—GAPDH—osteoporosis	1.18e-05	0.000802	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—PNP—osteoporosis	1.18e-05	0.000802	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—ATIC—osteoporosis	1.18e-05	0.000802	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—ATIC—osteoporosis	1.17e-05	0.000795	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—PNP—osteoporosis	1.17e-05	0.000795	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—FDPS—osteoporosis	1.16e-05	0.000783	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—PKM—osteoporosis	1.16e-05	0.000783	CbGpPWpGaD
Diphenhydramine—SLC22A1—Metabolism—RAP1A—osteoporosis	1.15e-05	0.000781	CbGpPWpGaD
Diphenhydramine—HRH1—GPCR ligand binding—POMC—osteoporosis	1.15e-05	0.000778	CbGpPWpGaD
Diphenhydramine—CHRM2—GPCR ligand binding—POMC—osteoporosis	1.13e-05	0.000766	CbGpPWpGaD
Diphenhydramine—CYP2B6—Metabolism—CYP27A1—osteoporosis	1.13e-05	0.000764	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling by GPCR—CALCA—osteoporosis	1.13e-05	0.000763	CbGpPWpGaD
Diphenhydramine—CHRM2—SIDS Susceptibility Pathways—IL6—osteoporosis	1.13e-05	0.000763	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling by GPCR—CALCA—osteoporosis	1.11e-05	0.000751	CbGpPWpGaD
Diphenhydramine—CYP2B6—Metabolism—ACP5—osteoporosis	1.1e-05	0.000743	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—PGLS—osteoporosis	1.1e-05	0.000742	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—GPD2—osteoporosis	1.1e-05	0.000742	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—CA2—osteoporosis	1.09e-05	0.000741	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—OXCT1—osteoporosis	1.09e-05	0.000741	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—TLN1—osteoporosis	1.09e-05	0.000737	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—TLN1—osteoporosis	1.07e-05	0.000725	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—MGLL—osteoporosis	1.07e-05	0.000722	CbGpPWpGaD
Diphenhydramine—PTGS1—Metabolism of lipids and lipoproteins—POMC—osteoporosis	1.05e-05	0.00071	CbGpPWpGaD
Diphenhydramine—CYP2B6—Metabolism—TPI1—osteoporosis	1.02e-05	0.000691	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—OXCT1—osteoporosis	1.01e-05	0.000682	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—CA2—osteoporosis	1.01e-05	0.000682	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	1.01e-05	0.000681	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—PNP—osteoporosis	1e-05	0.000679	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—ATIC—osteoporosis	1e-05	0.000679	CbGpPWpGaD
Diphenhydramine—SLC22A2—Metabolism—ENO1—osteoporosis	1e-05	0.000678	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—OXCT1—osteoporosis	9.97e-06	0.000676	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—CA2—osteoporosis	9.97e-06	0.000676	CbGpPWpGaD
Diphenhydramine—SLC22A2—Metabolism—PSMA2—osteoporosis	9.86e-06	0.000668	CbGpPWpGaD
Diphenhydramine—SLC22A2—Metabolism—PSMA5—osteoporosis	9.86e-06	0.000668	CbGpPWpGaD
Diphenhydramine—CYP2C18—Metabolism—ADCY5—osteoporosis	9.84e-06	0.000667	CbGpPWpGaD
Diphenhydramine—CYP2C18—Metabolism—GPX1—osteoporosis	9.81e-06	0.000665	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—MGLL—osteoporosis	9.8e-06	0.000664	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—MGLL—osteoporosis	9.72e-06	0.000658	CbGpPWpGaD
Diphenhydramine—PTGS1—Metabolism—ENO1—osteoporosis	9.71e-06	0.000658	CbGpPWpGaD
Diphenhydramine—CYP2B6—Metabolism—P4HB—osteoporosis	9.59e-06	0.00065	CbGpPWpGaD
Diphenhydramine—PTGS1—Metabolism—PSMA5—osteoporosis	9.57e-06	0.000648	CbGpPWpGaD
Diphenhydramine—PTGS1—Metabolism—PSMA2—osteoporosis	9.57e-06	0.000648	CbGpPWpGaD
Diphenhydramine—CYP2B6—Metabolism—GAPDH—osteoporosis	9.41e-06	0.000638	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—P4HB—osteoporosis	9.38e-06	0.000635	CbGpPWpGaD
Diphenhydramine—SLC22A1—Metabolism—ENO1—osteoporosis	9.32e-06	0.000632	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—P4HB—osteoporosis	9.23e-06	0.000625	CbGpPWpGaD
Diphenhydramine—SLC22A1—Metabolism—PSMA2—osteoporosis	9.19e-06	0.000622	CbGpPWpGaD
Diphenhydramine—SLC22A1—Metabolism—PSMA5—osteoporosis	9.19e-06	0.000622	CbGpPWpGaD
Diphenhydramine—CYP2B6—Metabolism—RAP1A—osteoporosis	9.17e-06	0.000621	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	9.17e-06	0.000621	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—PTH—osteoporosis	9.12e-06	0.000618	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—IDH2—osteoporosis	9.06e-06	0.000614	CbGpPWpGaD
Diphenhydramine—CYP2C18—Metabolism—MTHFR—osteoporosis	9.05e-06	0.000613	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—PTH—osteoporosis	8.98e-06	0.000608	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—RAP1A—osteoporosis	8.97e-06	0.000607	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—CNR2—osteoporosis	8.89e-06	0.000602	CbGpPWpGaD
Diphenhydramine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—osteoporosis	8.85e-06	0.0006	CbGpPWpGaD
Diphenhydramine—HRH1—GPCR downstream signaling—ADCY5—osteoporosis	8.83e-06	0.000598	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—RAP1A—osteoporosis	8.82e-06	0.000598	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—CNR2—osteoporosis	8.75e-06	0.000593	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—NFATC1—osteoporosis	8.75e-06	0.000593	CbGpPWpGaD
Diphenhydramine—CHRM2—GPCR downstream signaling—ADCY5—osteoporosis	8.68e-06	0.000588	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—DKK1—osteoporosis	8.68e-06	0.000588	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—NFATC1—osteoporosis	8.61e-06	0.000583	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—DKK1—osteoporosis	8.54e-06	0.000579	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—OXCT1—osteoporosis	8.52e-06	0.000577	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—CA2—osteoporosis	8.52e-06	0.000577	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—CYP27A1—osteoporosis	8.52e-06	0.000577	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—WNT1—osteoporosis	8.36e-06	0.000566	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—IDH2—osteoporosis	8.34e-06	0.000565	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—MGLL—osteoporosis	8.31e-06	0.000563	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—ACP5—osteoporosis	8.29e-06	0.000562	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—IDH2—osteoporosis	8.26e-06	0.00056	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—WNT1—osteoporosis	8.23e-06	0.000557	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	8.18e-06	0.000554	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—FGA—osteoporosis	8.13e-06	0.000551	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling by GPCR—ADCY5—osteoporosis	8.02e-06	0.000543	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—FGA—osteoporosis	8e-06	0.000542	CbGpPWpGaD
Diphenhydramine—SLC22A2—Metabolism—CYP19A1—osteoporosis	8e-06	0.000542	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling by GPCR—ADCY5—osteoporosis	7.89e-06	0.000534	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—CYP27A1—osteoporosis	7.84e-06	0.000531	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	7.83e-06	0.000531	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—CYP27A1—osteoporosis	7.77e-06	0.000526	CbGpPWpGaD
Diphenhydramine—PTGS1—Metabolism—CYP19A1—osteoporosis	7.76e-06	0.000526	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—TPI1—osteoporosis	7.71e-06	0.000522	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—ACP5—osteoporosis	7.62e-06	0.000517	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—BMP2—osteoporosis	7.56e-06	0.000512	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—PTHLH—osteoporosis	7.56e-06	0.000512	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—ACP5—osteoporosis	7.56e-06	0.000512	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	7.46e-06	0.000506	CbGpPWpGaD
Diphenhydramine—SLC22A1—Metabolism—CYP19A1—osteoporosis	7.45e-06	0.000505	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—PTHLH—osteoporosis	7.44e-06	0.000504	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—BMP2—osteoporosis	7.44e-06	0.000504	CbGpPWpGaD
Diphenhydramine—CYP2B6—Metabolism—ENO1—osteoporosis	7.41e-06	0.000502	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—FGB—osteoporosis	7.4e-06	0.000501	CbGpPWpGaD
Diphenhydramine—CYP2B6—Metabolism—PSMA2—osteoporosis	7.3e-06	0.000495	CbGpPWpGaD
Diphenhydramine—CYP2B6—Metabolism—PSMA5—osteoporosis	7.3e-06	0.000495	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—FGB—osteoporosis	7.28e-06	0.000493	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—P4HB—osteoporosis	7.25e-06	0.000491	CbGpPWpGaD
Diphenhydramine—CYP2C18—Metabolism—POMC—osteoporosis	7.24e-06	0.000491	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—PSMA2—osteoporosis	7.14e-06	0.000484	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—PSMA5—osteoporosis	7.14e-06	0.000484	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—GAPDH—osteoporosis	7.11e-06	0.000482	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—TPI1—osteoporosis	7.09e-06	0.00048	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—IDH2—osteoporosis	7.06e-06	0.000478	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—PSMA2—osteoporosis	7.03e-06	0.000476	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—PSMA5—osteoporosis	7.03e-06	0.000476	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—TPI1—osteoporosis	7.03e-06	0.000476	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—RAP1A—osteoporosis	6.93e-06	0.000469	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—P4HB—osteoporosis	6.66e-06	0.000451	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—CALCA—osteoporosis	6.66e-06	0.000451	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—CYP27A1—osteoporosis	6.64e-06	0.00045	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—P4HB—osteoporosis	6.61e-06	0.000448	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—CALCA—osteoporosis	6.55e-06	0.000444	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—GAPDH—osteoporosis	6.54e-06	0.000443	CbGpPWpGaD
Diphenhydramine—SLC22A2—Metabolism—ADCY5—osteoporosis	6.53e-06	0.000443	CbGpPWpGaD
Diphenhydramine—SLC22A2—Metabolism—GPX1—osteoporosis	6.51e-06	0.000441	CbGpPWpGaD
Diphenhydramine—HRH1—GPCR downstream signaling—POMC—osteoporosis	6.49e-06	0.00044	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—GAPDH—osteoporosis	6.49e-06	0.000439	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—ACP5—osteoporosis	6.46e-06	0.000438	CbGpPWpGaD
Diphenhydramine—CHRM2—GPCR downstream signaling—POMC—osteoporosis	6.39e-06	0.000433	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	6.38e-06	0.000432	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—RAP1A—osteoporosis	6.37e-06	0.000432	CbGpPWpGaD
Diphenhydramine—PTGS1—Metabolism—ADCY5—osteoporosis	6.34e-06	0.00043	CbGpPWpGaD
Diphenhydramine—PTGS1—Metabolism—GPX1—osteoporosis	6.32e-06	0.000428	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—RAP1A—osteoporosis	6.32e-06	0.000428	CbGpPWpGaD
Diphenhydramine—SLC22A1—Metabolism—ADCY5—osteoporosis	6.09e-06	0.000413	CbGpPWpGaD
Diphenhydramine—SLC22A1—Metabolism—GPX1—osteoporosis	6.07e-06	0.000411	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—KL—osteoporosis	6.04e-06	0.000409	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism of lipids and lipoproteins—POMC—osteoporosis	6.04e-06	0.000409	CbGpPWpGaD
Diphenhydramine—SLC22A2—Metabolism—MTHFR—osteoporosis	6.01e-06	0.000407	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—TPI1—osteoporosis	6e-06	0.000407	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—KL—osteoporosis	5.95e-06	0.000403	CbGpPWpGaD
Diphenhydramine—CYP2B6—Metabolism—CYP19A1—osteoporosis	5.92e-06	0.000401	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling by GPCR—POMC—osteoporosis	5.9e-06	0.000399	CbGpPWpGaD
Diphenhydramine—PTGS1—Metabolism—MTHFR—osteoporosis	5.83e-06	0.000395	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling by GPCR—POMC—osteoporosis	5.8e-06	0.000393	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling by GPCR—IL6R—osteoporosis	5.75e-06	0.00039	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling by GPCR—IL6R—osteoporosis	5.66e-06	0.000383	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—P4HB—osteoporosis	5.65e-06	0.000382	CbGpPWpGaD
Diphenhydramine—SLC22A1—Metabolism—MTHFR—osteoporosis	5.6e-06	0.000379	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—ENO1—osteoporosis	5.6e-06	0.000379	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—GAPDH—osteoporosis	5.54e-06	0.000375	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—PSMA2—osteoporosis	5.52e-06	0.000374	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—PSMA5—osteoporosis	5.52e-06	0.000374	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism of lipids and lipoproteins—POMC—osteoporosis	5.51e-06	0.000373	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—RAP1A—osteoporosis	5.4e-06	0.000366	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—ENO1—osteoporosis	5.15e-06	0.000349	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—ENO1—osteoporosis	5.11e-06	0.000346	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—PSMA2—osteoporosis	5.08e-06	0.000344	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—PSMA5—osteoporosis	5.08e-06	0.000344	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—PSMA5—osteoporosis	5.03e-06	0.000341	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—PSMA2—osteoporosis	5.03e-06	0.000341	CbGpPWpGaD
Diphenhydramine—CYP2B6—Metabolism—ADCY5—osteoporosis	4.84e-06	0.000328	CbGpPWpGaD
Diphenhydramine—CYP2B6—Metabolism—GPX1—osteoporosis	4.82e-06	0.000327	CbGpPWpGaD
Diphenhydramine—SLC22A2—Metabolism—POMC—osteoporosis	4.81e-06	0.000326	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—ADCY5—osteoporosis	4.73e-06	0.000321	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism of lipids and lipoproteins—POMC—osteoporosis	4.71e-06	0.000319	CbGpPWpGaD
Diphenhydramine—PTGS1—Metabolism—POMC—osteoporosis	4.67e-06	0.000316	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—ADCY5—osteoporosis	4.66e-06	0.000316	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—SPP1—osteoporosis	4.58e-06	0.00031	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—SPP1—osteoporosis	4.51e-06	0.000305	CbGpPWpGaD
Diphenhydramine—SLC22A1—Metabolism—POMC—osteoporosis	4.48e-06	0.000303	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—CYP19A1—osteoporosis	4.48e-06	0.000303	CbGpPWpGaD
Diphenhydramine—CYP2B6—Metabolism—MTHFR—osteoporosis	4.45e-06	0.000302	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—ENO1—osteoporosis	4.36e-06	0.000296	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—PSMA5—osteoporosis	4.3e-06	0.000291	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—PSMA2—osteoporosis	4.3e-06	0.000291	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—IRS2—osteoporosis	4.14e-06	0.000281	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—CYP19A1—osteoporosis	4.12e-06	0.000279	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—CYP19A1—osteoporosis	4.08e-06	0.000277	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—IRS2—osteoporosis	4.08e-06	0.000276	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—LEP—osteoporosis	4.05e-06	0.000275	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—LEP—osteoporosis	3.99e-06	0.00027	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—ESR1—osteoporosis	3.87e-06	0.000262	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—ESR1—osteoporosis	3.81e-06	0.000258	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—ADCY5—osteoporosis	3.66e-06	0.000248	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—GPX1—osteoporosis	3.65e-06	0.000247	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—IRS1—osteoporosis	3.62e-06	0.000245	CbGpPWpGaD
Diphenhydramine—CYP2B6—Metabolism—POMC—osteoporosis	3.56e-06	0.000241	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—IRS1—osteoporosis	3.56e-06	0.000241	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—CYP19A1—osteoporosis	3.49e-06	0.000236	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—POMC—osteoporosis	3.48e-06	0.000236	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—POMC—osteoporosis	3.43e-06	0.000232	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—IL6R—osteoporosis	3.4e-06	0.00023	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—ADCY5—osteoporosis	3.36e-06	0.000228	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—MTHFR—osteoporosis	3.36e-06	0.000228	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—GPX1—osteoporosis	3.35e-06	0.000227	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—IGF1—osteoporosis	3.35e-06	0.000227	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—IL6R—osteoporosis	3.34e-06	0.000226	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—ADCY5—osteoporosis	3.34e-06	0.000226	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—GPX1—osteoporosis	3.32e-06	0.000225	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—IGF1—osteoporosis	3.3e-06	0.000223	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—MTHFR—osteoporosis	3.09e-06	0.00021	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—MTHFR—osteoporosis	3.07e-06	0.000208	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—ADCY5—osteoporosis	2.85e-06	0.000193	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—GPX1—osteoporosis	2.84e-06	0.000192	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—POMC—osteoporosis	2.69e-06	0.000182	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—MTHFR—osteoporosis	2.62e-06	0.000178	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling by GPCR—IL6—osteoporosis	2.56e-06	0.000174	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling by GPCR—IL6—osteoporosis	2.52e-06	0.000171	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—POMC—osteoporosis	2.47e-06	0.000168	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—POMC—osteoporosis	2.45e-06	0.000166	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—POMC—osteoporosis	2.1e-06	0.000142	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—MYC—osteoporosis	2.01e-06	0.000136	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—TGFB1—osteoporosis	2.01e-06	0.000136	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—MYC—osteoporosis	1.98e-06	0.000134	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—TGFB1—osteoporosis	1.98e-06	0.000134	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—IL6—osteoporosis	1.51e-06	0.000103	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—IL6—osteoporosis	1.49e-06	0.000101	CbGpPWpGaD
